AU2002238994A1 - Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody - Google Patents

Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody

Info

Publication number
AU2002238994A1
AU2002238994A1 AU2002238994A AU2002238994A AU2002238994A1 AU 2002238994 A1 AU2002238994 A1 AU 2002238994A1 AU 2002238994 A AU2002238994 A AU 2002238994A AU 2002238994 A AU2002238994 A AU 2002238994A AU 2002238994 A1 AU2002238994 A1 AU 2002238994A1
Authority
AU
Australia
Prior art keywords
dna
producing
nucleosome
assaying
plate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002238994A
Inventor
Yoshiyuki Kanai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Todai TLO Ltd
Original Assignee
Todai TLO Ltd
Center for Advanced Science and Technology Incubation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Todai TLO Ltd, Center for Advanced Science and Technology Incubation Ltd filed Critical Todai TLO Ltd
Priority claimed from PCT/JP2002/002664 external-priority patent/WO2002076377A1/en
Publication of AU2002238994A1 publication Critical patent/AU2002238994A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875Nucleoproteins
AU2002238994A 2001-03-23 2002-03-20 Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody Abandoned AU2002238994A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001-84480 2001-03-23
JP2001084480 2001-03-23
JP2001291182 2001-09-25
JP2001-291182 2001-09-25
PCT/JP2002/002664 WO2002076377A1 (en) 2001-03-23 2002-03-20 Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody

Publications (1)

Publication Number Publication Date
AU2002238994A1 true AU2002238994A1 (en) 2002-10-08

Family

ID=26611884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002238994A Abandoned AU2002238994A1 (en) 2001-03-23 2002-03-20 Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody

Country Status (2)

Country Link
JP (1) JP4276843B2 (en)
AU (1) AU2002238994A1 (en)

Also Published As

Publication number Publication date
WO2002076377A3 (en) 2002-11-21
JPWO2002076377A1 (en) 2004-07-08
WO2002076377A2 (en) 2002-10-03
JP4276843B2 (en) 2009-06-10

Similar Documents

Publication Publication Date Title
AU2965500A (en) Immobilized nucleic acid hybridization reagent and method
AU2001253655A1 (en) Multi-well plate and method of manufacture
AU2002239826A1 (en) Methods and reagents for the isolation of nucleic acids
AU2002239839A1 (en) Laboratory database system and methods for combinatorial materials research
AU3027699A (en) Nucleic acid analysis method
AU2001244609A1 (en) Novel protein, dna thereof and process for producing the same
WO2000042188A3 (en) Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
AU2002314227A1 (en) Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
AU8388098A (en) Assays for diagnosis of thrombophilic disease
EP1544291A4 (en) Novel process for producing antibody enzyme, novel antibody enzyme and utilization thereof
AU2001267485A1 (en) Method for the analysis of picomole amounts of carbohydrates
AU6458400A (en) Nucleic acid, polypeptides, assays, therapeutic methods and means
AU2002367943A1 (en) Improved reagents and methods for producing parvoviruses
AU3717600A (en) Methods and reagents for decreasing clinical reaction to allergy
AU1742600A (en) Identification of disease predictive nucleic acids
AU2002306850A1 (en) Methods and reagents for decreasing clinical reaction to allergy
AU9372698A (en) An (in vitro) activity assay for human hepatits b virus (hbv) dna polymerase, the use of such an assay to assay activity of various serum samples and to screen for inhibitors of the hbv dna polymerase and a method of producing hbv dna polymerase
AU2002238994A1 (en) Mononucleosome and process for producing the same, method of assaying antibody specific to nucleosome, method of diagnosing autoimmune disease, process for producing nucleosome dna, dna plate, process for producing dna plate and method of assaying anti-dna antibody
AU2003274065A1 (en) New probe plate based on antigen-antibody reaction and reagent kit and method using the probe plate
EP1391519A4 (en) Nonspecific hybridization inhibitors, clinical examination reagents and clinical examination method
IL134717A0 (en) Method for increasing the performance of immobilized biocatalysts, and catalysts obtained thereby
AU2002317672A1 (en) Method for the biochemical detection of analytes
AUPS064202A0 (en) Improved method for the analysis of nucleic acid samples
AU2001267922A1 (en) Method of assaying the function of fc fragment of antibody
AU2746999A (en) Ige antibody production inhibitors and autoimmune diseases inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase